NCT02286843 2021-06-18
Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
Memorial Sloan Kettering Cancer Center
Phase NA Completed
Clinical Trials
4 trialsNCT04882371 2021-05-11
Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer
Istanbul Medeniyet University
Completed
NCT01892540 2020-03-04
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT02681640 2017-04-06
uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Rigshospitalet, Denmark
Phase 2 Completed